250 related articles for article (PubMed ID: 24475290)
1. Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.
Cacan E; Ali MW; Boyd NH; Hooks SB; Greer SF
PLoS One; 2014; 9(1):e87455. PubMed ID: 24475290
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells.
Ali MW; Cacan E; Liu Y; Pierce JY; Creasman WT; Murph MM; Govindarajan R; Eblen ST; Greer SF; Hooks SB
PLoS One; 2013; 8(3):e60185. PubMed ID: 23533674
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells.
Cacan E
J Chemother; 2017 Jun; 29(3):173-178. PubMed ID: 28102109
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic-mediated immune suppression of positive co-stimulatory molecules in chemoresistant ovarian cancer cells.
Cacan E
Cell Biol Int; 2017 Mar; 41(3):328-339. PubMed ID: 28074529
[TBL] [Abstract][Full Text] [Related]
5. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.
Hooks SB; Callihan P; Altman MK; Hurst JH; Ali MW; Murph MM
Mol Cancer; 2010 Nov; 9():289. PubMed ID: 21044322
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells.
Ceccarelli V; Ronchetti S; Marchetti MC; Calvitti M; Riccardi C; Grignani F; Vecchini A
Biochim Biophys Acta Gene Regul Mech; 2020 Feb; 1863(2):194481. PubMed ID: 31923609
[TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylase-1-mediated Suppression of FAS in Chemoresistant Ovarian Cancer Cells.
Cacan E
Anticancer Res; 2016 Jun; 36(6):2819-26. PubMed ID: 27272793
[TBL] [Abstract][Full Text] [Related]
8. A broad analysis in clinical and in vitro models on regulator of G-protein signalling 10 regulation that is associated with ovarian cancer progression and chemoresistance.
Kucuk B; Kibar B; Cacan E
Cell Biochem Funct; 2021 Apr; 39(3):413-422. PubMed ID: 33354811
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.
Arabsolghar R; Azimi T; Rasti M
Mol Biol Rep; 2013 Mar; 40(3):2617-25. PubMed ID: 23242655
[TBL] [Abstract][Full Text] [Related]
10. RGS10 suppression by DNA methylation is associated with low survival rates in colorectal carcinoma.
Caldiran FY; Cacan E
Pathol Res Pract; 2022 Aug; 236():154007. PubMed ID: 35810565
[TBL] [Abstract][Full Text] [Related]
11. Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer.
Brodie SA; Li G; El-Kommos A; Kang H; Ramalingam SS; Behera M; Gandhi K; Kowalski J; Sica GL; Khuri FR; Vertino PM; Brandes JC
Cancer Prev Res (Phila); 2014 Mar; 7(3):351-61. PubMed ID: 24441677
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
Estève PO; Chin HG; Pradhan S
J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
[TBL] [Abstract][Full Text] [Related]
13. Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer.
Hooks SB; Murph MM
Future Med Chem; 2015 Aug; 7(12):1483-9. PubMed ID: 26293348
[TBL] [Abstract][Full Text] [Related]
14. Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity.
Alqinyah M; Maganti N; Ali MW; Yadav R; Gao M; Cacan E; Weng HR; Greer SF; Hooks SB
Mol Pharmacol; 2017 Mar; 91(3):197-207. PubMed ID: 28031332
[TBL] [Abstract][Full Text] [Related]
15. RGS10 Regulates the Expression of Cyclooxygenase-2 and Tumor Necrosis Factor Alpha through a G Protein-Independent Mechanism.
Alqinyah M; Almutairi F; Wendimu MY; Hooks SB
Mol Pharmacol; 2018 Oct; 94(4):1103-1113. PubMed ID: 30049816
[TBL] [Abstract][Full Text] [Related]
16. The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes.
Cai Y; Geutjes EJ; de Lint K; Roepman P; Bruurs L; Yu LR; Wang W; van Blijswijk J; Mohammad H; de Rink I; Bernards R; Baylin SB
Oncogene; 2014 Apr; 33(17):2157-68. PubMed ID: 23708667
[TBL] [Abstract][Full Text] [Related]
17. HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells.
Chen DQ; Pan BZ; Huang JY; Zhang K; Cui SY; De W; Wang R; Chen LB
Oncotarget; 2014 May; 5(10):3333-49. PubMed ID: 24830600
[TBL] [Abstract][Full Text] [Related]
18. 8a, a New Acridine Antiproliferative and Pro-Apoptotic Agent Targeting HDAC1/DNMT1.
Zhang Q; Wang Z; Chen X; Qiu H; Gu Y; Wang N; Wang T; Wang Z; Ma H; Zhao Y; Zhang B
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073721
[TBL] [Abstract][Full Text] [Related]
19. Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells.
Karaca B; Atmaca H; Bozkurt E; Kisim A; Uzunoglu S; Karabulut B; Sezgin C; Sanli UA; Uslu R
Mol Biol Rep; 2013 Jun; 40(6):3925-33. PubMed ID: 23269627
[TBL] [Abstract][Full Text] [Related]
20. Development of a versatile DNMT and HDAC inhibitor C02S modulating multiple cancer hallmarks for breast cancer therapy.
Yuan Z; Chen S; Gao C; Dai Q; Zhang C; Sun Q; Lin JS; Guo C; Chen Y; Jiang Y
Bioorg Chem; 2019 Jun; 87():200-208. PubMed ID: 30901675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]